Immunotherapeutic Agents for Intratumoral Immunotherapy

Immunotherapy using systemic immune checkpoint inhibitors (ICI) and chimeric antigen receptor (CAR) T cells has revolutionized cancer treatment, but it only benefits a subset of patients. Systemic immunotherapies cause severe autoimmune toxicities and cytokine storms. Immune-related adverse events (...

Descripción completa

Detalles Bibliográficos
Autores principales: Shyr, Chih-Rong, Liu, Lang-Chi, Chien, Hui-Shan, Huang, Chi-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674963/
https://www.ncbi.nlm.nih.gov/pubmed/38006049
http://dx.doi.org/10.3390/vaccines11111717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674963/
https://www.ncbi.nlm.nih.gov/pubmed/38006049
http://dx.doi.org/10.3390/vaccines11111717

Ejemplares similares